Kim JH - Search Results

1

SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.

Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. Zhu Y, et al. Among authors: kim jh. Cancers (Basel). 2021 Apr 8;13(8):1777. doi: 10.3390/cancers13081777. Cancers (Basel). 2021. PMID: 33917869 Free PMC article.

2

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW, Mok SC. Kim JH, et al. JAMA. 2002 Apr 3;287(13):1671-9. doi: 10.1001/jama.287.13.1671. JAMA. 2002. PMID: 11926891

3

Osteopontin is down-regulated in hydatidiform mole.

Batorfi J, Fulop V, Kim JH, Genest DR, Doszpod J, Mok SC, Berkowitz RS. Batorfi J, et al. Among authors: kim jh. Gynecol Oncol. 2003 Apr;89(1):134-9. doi: 10.1016/s0090-8258(03)00067-2. Gynecol Oncol. 2003. PMID: 12694667

4

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC. Kim JH, et al. Clin Cancer Res. 2003 Oct 15;9(13):4782-91. Clin Cancer Res. 2003. PMID: 14581349

5

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.

Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Schorge JO, et al. Among authors: kim jh. Clin Cancer Res. 2004 May 15;10(10):3474-8. doi: 10.1158/1078-0432.CCR-03-0365. Clin Cancer Res. 2004. PMID: 15161704

6

Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.

Gagnon A, Kim JH, Schorge JO, Ye B, Liu B, Hasselblatt K, Welch WR, Bandera CA, Mok SC. Gagnon A, et al. Among authors: kim jh. Clin Cancer Res. 2008 Feb 1;14(3):764-71. doi: 10.1158/1078-0432.CCR-07-0856. Clin Cancer Res. 2008. PMID: 18245537 Free article.

7

Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression.

Shin HY, Yang W, Lee EJ, Han GH, Cho H, Chay DB, Kim JH. Shin HY, et al. Among authors: kim jh. PLoS One. 2018 Oct 8;13(10):e0205297. doi: 10.1371/journal.pone.0205297. eCollection 2018. PLoS One. 2018. PMID: 30296284 Free PMC article.

8

Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth.

Yang W, Han GH, Shin HY, Lee EJ, Cho H, Chay DB, Kim JH. Yang W, et al. Among authors: kim jh. Int J Hyperthermia. 2019;36(1):9-20. doi: 10.1080/02656736.2018.1528390. Epub 2018 Nov 14. Int J Hyperthermia. 2019. PMID: 30428738 Free article.

9

Current Status of Human Papillomavirus Infection and Introduction of Vaccination to the National Immunization Program in Korea: an Overview.

Kim MA, Han GH, Kim JH, Seo K. Kim MA, et al. Among authors: kim jh. J Korean Med Sci. 2018 Nov 28;33(52):e331. doi: 10.3346/jkms.2018.33.e331. eCollection 2018 Dec 24. J Korean Med Sci. 2018. PMID: 30584412 Free PMC article. Review.

10

ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer.

Choi JA, Kwon H, Cho H, Chung JY, Hewitt SM, Kim JH. Choi JA, et al. Among authors: kim jh. Cancers (Basel). 2019 Oct 14;11(10):1553. doi: 10.3390/cancers11101553. Cancers (Basel). 2019. PMID: 31615043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31,109 results

Search Page